(Total Views: 503)
Posted On: 01/07/2022 4:35:57 PM
Post# of 154090
Missing comas is all.
Quote:
If approved by the FDA, patients in this trial will be randomized in a 1:1 ratio to receive up to four doses of 700 mg leronlimab, with standard of care or placebo with standard of care, administered by 30-minute IV infusion weekly over a four-week treatment period.
Read More: https://investorshangout.com/post/view?id=629...z7HK5uEnuz
(0)
(0)
